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Purpose: To determine whether Mel4-coated antimicrobial contact lenses (MACLs) can
reduce the incidence of corneal infiltrative events (CIEs) during extended wear.
Methods: A prospective, randomized, double-masked, single-center, contralateral,
extended contact lens wear clinical trial was conducted with 176 subjects. Each partici-
pantwas randomly assigned towear aMACL in one eye and anuncoated control contact
lens in the contralateral eye or an extended-wear biweekly disposable modality for
3 months. Themain outcomemeasures were the incidence of CIEs per 100 eye-months,
identification of the microbial types colonizing the contact lenses or eyes at the time of
the CIEs, and their susceptibility to Mel4.
Results: Nine participants (5.1%) experienced unilateral CIEs; six participants had
contact lens acute red eye, and three participants had infiltrative keratitis. The incidence
rate for CIEs (0.4 events per 100 participant months; 1.7%) in the Mel4-coated lenses
(test)was 69% less than that of the control lenses (1.3 events per 100participantmonths;
3.4%; P = 0.29). All Gram-negative bacteria isolated from lenses and lids of participants
with CIEs (Citrobacter diversus, Acinetobacter haemolyticus, and Acinetobacter lwoffii)
were susceptible to Mel4 peptide; minimum inhibitory concentrations ranged from
15.6 to 62.5 μg/mL. Reduction of adhesion of these bacteria by Mel4-coated lenses
ranged from 2.1 to 2.2 log10 colony-forming units/lens.
Conclusions: MACLs had the capacity to reduce CIEs by at least 50% compared with
uncoated control lenses during extended wear over 3 months; however, due to the
relatively low rates of CIEs, the reduction was not statistically different compared with
control lenses.
Translational Relevance: This study provides evidence that antimicrobial contact
lenses have the potential to reduce the incidence of corneal infiltrative events during
extended wear.
Introduction
Microbial contamination of contact lenses may
lead to corneal infection or inflammatory events
such as microbial keratitis (MK), contact lens
acute red eye (CLARE) and contact lens periph-
eral ulcers (CLPUs).1–4 Pseudomonas aeruginosa is the
most common microbe associated with MK during
contact lens wear.5,6 CLARE is commonly caused by
Gram-negative colonization of contact lenses,7–9 and
CLPUs are commonly associated with Gram-positive
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contamination of contact lenses.9,10 Collectively, along
with infiltrative keratitis (IK), which can also be associ-
ated with microbial contamination of lenses,1,7 these
adverse events are known as microbially driven corneal
infiltrative events (CIEs).
The incidence of MK per year for extended wear of
contact lenses is approximately 20 per 10,000 wearers;
for daily wear, it is approximately three per 10,000
wearers.11–15 The incidence of other bacterially driven
CIEs is approximately 0.5 to 26.7 per 100 wearers
during extended wear 16–19 and 0 to 25.5 per 100 eyes
during daily wear.3,17,20,21 The use of silicone hydrogel
lenses has been associated with a two-times greater risk
of CIEs.18
Inhibition of microbial adhesion to contact lenses
during wear is likely to reduce the incidence of CIEs.
Several potential antimicrobial contact lenses have
been produced, although most have not progressed
to human clinical trials. Impregnation of silver into
etafilcon A hydrogel contact lenses reduced micro-
bial colonization in an in vitro study.22 Selenium (Se)
covalently coated onto balafilcon A silicone hydro-
gel lenses reduced bacterial colonization in vitro while
not adversely affecting the corneal health of rabbits
in vivo.23 The overall clinical performance of the Se-
coated lenses was comparable to that of the commer-
cially available balafilcon A lens, and the efficacy of
Se-coated lenses was maintained after 24 hours of
extended wear.24 Fimbrolide covalently attached to
lotrafilcon A (silicone hydrogel) contact lenses showed
good antibacterial activity, and there were no signif-
icant differences in ocular responses to fimbrolide-
coated lenses compared with uncoated control lenses
in either a 1-month animal trial or an overnight human
trial.25 The arginine- and lysine-rich, 29-amino-acid
peptide melimine, when immobilized on contact lenses,
reduced the severity and incidence of CLARE,CLPUs,
and MK in animal models and was not cytotoxic to
mammalian cells in vitro.26–28 Clinical responses to
wearing melimine-coated hydrogel contact lenses did
not differ from those to wearing uncoated control
lenses in animal safety trials; in human trials, an
increase in punctate fluorescein corneal staining after
1 day of wear has been reported.27,28 Due to the
increase in punctate fluorescein corneal staining, a
shorter derivative of melimine, referred to as Mel4,
was developed. Mel4-coated silicone hydrogel lenses
(lotrafilcon A, comfilcon A, and somofilcon A) showed
a high level of antimicrobial inhibition in vitro and did
not have any cytotoxic effects in vivo when rabbits wore
them for 1 week.29 Furthermore, Mel4-coated hydro-
gel lenses showed no evidence of corneal staining in
human phase I clinical trials.29–31
The current study was designed to determine
whether Mel4-coated lenses can reduce the incidence
of microbially driven CIEs during extended wear. This
study hypothesized that etafilcon A lenses coated with
Mel4 would be able to reduce the incidence of micro-
bially driven CIEs due to extended wear.
Materials and Methods
Production of Mel4-Coated Contact Lenses
Etafilcon A contact lenses (Acuvue 2; Johnson
& Johnson Vision Care, Jacksonville, FL) were used
for this study. Mel4 peptide (amino acid sequence,
KNKRKRRRRRRGGRRRR; American Peptide
Company, Sunnyvale, CA) was synthesized by conven-
tional solid-phase peptide synthesis with >95% purity.
The procedure for covalently attachingMel4 to contact
lenses has been reported elsewhere.28,30–32 Briefly,
washed contact lenses were placed in 0.1 mol/L sodium
acetate buffer, pH 5.0, containing 2 mg/mL 1-ethyl-3-
(3-dimethylaminopropyl) carbodiimide hydrochloride
(EDC) with 0.3 mg/mL N-hydroxysuccinimide for 30
minutes at 28°C. After washing in phosphate-buffered
saline (PBS) the lenses were resuspended in 3.1 mg/mL
of Mel4 in PBS and incubated for 20 hours at 37°C.
Subsequently, lenses were washed three times in sterile
PBS and then resuspended in 2 mL of 10% w/v NaCl
for 2 hours at 28°C. This was followed by soaking
in PBS for 2 hours and autoclaving at 121°C for 20
minutes. The lenses were then stored in glass vials at
room temperature. Control etafilcon A lenses were
removed from their packs, washed, and autoclaved in
glass vials, as above.
Quantification of Mel4 Peptide Attachment
and Activity on Contact Lenses
Mel4-coated lenses for the clinical trial were
produced in 31 different batches. Amino acid analy-
sis was performed using high-performance liquid
chromatography to quantify the presence of Mel4
peptide on the coated lenses. Two Mel4-coated lenses
from each batch were assessed by amino acid analy-
sis to confirm the presence and amount of peptide
on the lens surface. Briefly, Milli-Q (MilliporeSigma,
Billerica, MA) water was used to wash Mel4-coated
and control uncoated lenses. The lenses then under-
went 24 hours of gas-phase hydrolysis in 6-M HCl
(Ajax Finechem, Taren Point, NSW, Australia) at
110°C. Amino acids were extracted into 20% acetoni-
trile with trifluoroacetic acid (ThermoFisher Scientific,
Waltham,MA) and analyzed using an AccQ-Tag Ultra
Downloaded from tvst.arvojournals.org on 07/05/2021
Effect of Antimicrobial Contact Lenses on CIEs TVST | June 2021 | Vol. 10 | No. 7 | Article 32 | 3
chemistry kit (Waters Corp., Milford, MA). The sum
of all of the amino acids derived from the lens was
regarded as the total amount of Mel4 attached to the
lens surface.
After the production of Mel4-coated lenses and
prior to the lens-dispensing visit, two Mel4-coated
and control lenses from each batch were assessed for
adhesion of P. aeruginosa ATCC 27853 and Staphylo-
coccus aureus L2260/15. The bacterial adhesion proto-
col has been reported in prior studies.30,33 Briefly, 1.0×
106 colony-forming units (CFU)/mL of bacterial cell
suspensions in 1× PBS were transferred to the wells
of 24-well tissue culture plates containing control or
Mel4-coated lenses. The plates were incubated for 18
hours with shaking (120 rpm) at 37°C. The lenses were
then washed three times with 1× PBS and then stirred
in a vortex mixer rapidly in 2 mL of fresh 1× PBS
containing a small magnetic stirring bar for a minute.
The resulting lens slurry was serially diluted (1/10), and
3 × 20 μL of each dilution was transferred to nutri-
ent agar for recovery of cells. After incubation for 24
hours at 37°C, viable microorganisms were enumerated
as CFU/mm2 of a lens.
Study Participants
All procedures were conducted according to the
tenets of the Declaration of Helsinki and were
approved by the Human Research Ethics Committee
of the University of New South Wales (HC15436) and
the Institutional Ethics Committee of Hyderabad Eye
Research Foundation (LEC 05-15-057). Also, the clini-
cal trial was registered with Clinical Trials Registry–
India (CTRI Trial ID CTRI/2015/10/006327) follow-
ing approval from the Central Drugs Standard Control
Organization and Drug Controller General of India
(DCGI 4-MD/CT-148/2015-DC). The inclusion crite-
ria required participants to be older than 18 years
and in good health, to not be taking any medica-
tions, and to have correctable vision to 6/12 or better
in each eye. Also required were contact lens correc-
tion between –1.00 and –6.00 diopter (D) sphere and
the subject to be either experienced or new to contact
lens wear. The exclusion criteria were any pre-existing
ocular irritation; injury or condition (including infec-
tion or disease) of the cornea, conjunctiva, or eyelids
that would interfere with contact lens fitting and the
safewearing of contact lenses; any systemic disease; eye
surgery; systemic or topical medication up to 12 weeks
before or during the trial that could adversely affect
ocular health; and being or planning on becoming
pregnant. All participants gave prior informed consent,
and all were residents of Hyderabad, Telangana, India.
The study was conducted at the L V Prasad Eye Insti-
tute (LVPEI), Hyderabad, India.
The study sample size was calculated based on a
previous study at the same site,34 which reported that
the rate of CIEs within 3 months of extended contact
lens wear was 6.7%. The sample size for this study was
estimated for incidence rates over 3months represented
as events per 100 participant months. PS software
was used to calculate sample sizes.35 A total of 415
participant-months was required to determine a differ-
ence in incidence rates of 6.7 versus 2.4% at a 5% level
of significance with 80% power. A low correlation of
0.15 for the CIE outcome between matched test and
control eyes was used in the calculations. The sample
was adjusted for a 15% loss of data over 3 months.
The resulting sample of 495 participant months was
divided by 3 months to arrive at a minimum sample of
165 participants.
Clinical Trial Design
This Mel4-coated antimicrobial contact lens clini-
cal trial was a phase II/III, prospective, randomized,
double-masked, single-center, contralateral design with
3 months of extended contact lens wear. Partici-
pants were randomized (using a computer-generated
random allocation table) to wear Mel4-coated antimi-
crobial contact lens in one eye and uncoated etafilcon
A control lenses in the contralateral eye. All of the
participants were instructed to replace the lenses every
2 weeks.
The study required seven visits: baseline (visit 1),
lens dispensing (visit 2), one night of lens wear (visit
3), 2 weeks of lens wear (visit 4), 1 month of lens
wear (visit 5), and 3 months of lens wear (visit 6),
followed by a 1 month follow-up visit after study lens
discontinuation (visit 7). The seventh follow-up visit
to test for any delayed responses to the investiga-
tional product at the end of 3 months of extended
wear did not assign contact lens wear, and the partic-
ipants were free to wear their glasses, if desired.
Experienced wearers were given study lenses at the
baseline visit. For adaptation purposes, neophytes
were required to wear commercially available etafil-
con A (Acuvue 2) lenses for 1 week on a daily-wear
schedule using Biotrue contact lens cleaning solution
(Bausch&Lomb,Rochester, NY) for rinsing and disin-
fecting the lenses. Study lenses were then dispensed
at the subsequent lens dispensing visit. To reduce
the possibility of participants mixing right and left
eye lenses, all right eye and left eye lens vials were
affixed with green and white labels, respectively. The
baseline visit included health and contact lens history,
keratometry, subjective refraction, and visual acuity
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assessments. All measurements for the study were
performed by optometrists who were masked as to
the types of lenses worn in each eye. At each visit,
ocular characteristics and subjective responses of each
subject were assessed. Slit-lamp biomicroscopy was
performed for anterior eye assessment and included
bulbar, limbal and palpebral redness, palpebral rough-
ness, and conjunctival and corneal staining using
standard clinical techniques and standardized grading
scales. All of the clinical grading was conducted using
the Cornea and Contact Lens Research Unit grading
scales36 (0 to 4 units) interpolated into 0.1 incre-
ments, except for corneal staining, which was graded
in 1.0 steps for extent and depth and 0.5 steps for
type. Concordance training for the optometrists was
conducted before study commencement, and concor-
dance was measured every 6 months during the study.
Allmasked optometrists were allowed to examine study
participants if they scored more than 70% concor-
dance for each grading scale, and they were retrained
if concordance dropped below this level.
If the participants needed to remove their lenses
temporarily, they were given Biotrue contact lens care
solution and a case only for temporary storage. All
participants were issued with a “red eye kit” at the
end of the lens dispensing visit which consisted of a
single 5-mL unit dose of sterile saline (sodium chloride;
Pfizer, Sydney, Australia) and a fresh lens case (Bausch
& Lomb) with right (R) and left (L) clearly marked
with colored stickers. In the case of unusual symptoms
such as redness, pain, watering, photophobia, decrease
in vision, or noticing a white spot on the eye, partic-
ipants were instructed to report to the clinic at their
earliest possible convenience, or, if unable to present
to the clinic, they were instructed to wash their hands
with soap and air dry their hands before lens removal.
Further, they were asked to use the red eye kit and place
an approximately 2.5-mL unit dose of sterile saline in
each lens case well, aseptically placing the right and left
eye contact lenses appropriately. They were also asked
to present to the clinic as soon as possible along with
their red eye kit. The primary outcome measure for
this clinical trial was the incidence of microbially driven
adverse events (corneal infiltrative events) in each eye
of the participants.
Adverse Events
The clinical assessment and classification of CIEs
were adopted from previous studies.37,38 MK was
classified as a serious adverse event. Significant events
included CLARE, CLPUs, or IK. Non-significant
events included asymptomatic IK or asymptomatic
infiltrates. During the presentation of any adverse
event, clinical optometrists made a primary diagno-
sis.37 A clinical audit team consisting of optometrists,
ophthalmologists, and basic scientists reviewed all of
the cases to confirm or amend the diagnosis prior to
data analysis. All participants who were classified as
having a CIE were permanently discontinued from lens
wear and the study, and they were regularly monitored
until the condition resolved completely. In the event of
adverse events, upper bulbar conjunctiva and lower lid
swabs, as well as contact lenses that had been worn,
where available, were aseptically collected formicrobio-
logical analysis. Aseptically collected contact lenses and
swabs from theCIE participants were placed in 2mLof
sterile PBS and transported immediately to the micro-
biology laboratory for analysis. The methodology for
processing collected contact lenses and swabs has been
described elsewhere.39,40
Susceptibility of Microbes to Mel4 Peptide
Gram-negative bacteria are the most common
bacteria type isolated from contact lenses. When CIEs
have occurred in previous studies,1,7–9 the susceptibil-
ity to Mel4 of Gram-negative bacteria isolated from
swabs or lenses at the time of a CIE was assessed by
determining the minimum inhibitory concentration of
Mel4 that reduced the growth of the microbes by 50%
using a previously published method.30 The adhesion
of these Gram-negative bacteria to Mel4 and control
lenses was also examined as outlined above forP. aerug-
inosa 27853.
Statistical Analysis
The rate of CIEs was expressed as a rate per 100
participant-months. The differences in the incidence of
CIEs between participants wearing the test lenses and
those wearing the control lenses were compared using
the McNemar test. The log-rank (Mantel–Cox) test
was used to examine the survival analysis of partici-
pants who had CIEs. A Mann–Whitney test was used
to assess differences in the numbers of bacteria adher-
ing to the Mel4-coated and control lenses. For all
tests, the level of statistical significance was set at
P < 0.05.
Results
A total of 775 participants (neophytes and
experienced contact lens wearers) were screened for
suitability. Of these, 176 participants (128 neophytes
and 48 experienced contact lens wearers) were enrolled
and given study lenses between January 2015 to
December 2017. The participants were 18 to 42 years
old and had contact lens powers ranging from –1.00
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Figure 1. CIE rates for the Mel4-coated lenses and control lenses: (A) all participants, and (B) after removing the participant who wore the
lenses for 22 days (exceeding the maximum number of days allowed in the trial).
to –6.00 D sphere. Baseline clinical characteristics of
the subjects are shown in Supplementary Table S1. All
participants achieved visual acuity of at least 6/12 or
better with correction and were willing to comply with
wearing the study contact lenses. Among the partici-
pants, 129 completed the 4-month study. Thirty-nine
participants (22%) discontinued lens wear perma-
nently prior to completion of the study due to adverse
events, fever, epidemic viral conjunctivitis, chickenpox,
relocation, or disinterest. Another eight participants
(5%) were lost to follow-up during the study.
Analyses of Mel4-Coated Lenses Prior to Lens
Wear
More than 1500 Mel4-coated lenses were produced
for the clinical trial in 31 batches. The amino acid analy-
ses revealed that the Mel4-coated contact lenses had
62.6± 26.4 μg of Mel4 peptide per lens, confirming that
the lenses had been coated with Mel4 peptide. Unworn
Mel4-coated lenses significantly reduced the adhesion
of P. aeruginosa (2.42± 1.16 log10 CFU/lens reduction;
P < 0.001) and S. aureus (1.82 ± 0.46 log10 CFU/lens
reduction; P < 0.001) compared with control uncoated
lenses. These results demonstrate that the participants
in the trial were prescribed with active Mel4-coated
contact lenses.
Incidence of Contact Lens-Induced Corneal
Infiltrative Events
During the 3 months of extended lens wear, nine
participants (5.1%; nine eyes of the nine participants)
experienced CIEs. These nine participants included
three participants (1.7%; three eyes) who wore the
Mel4-coated lenses and six participants (3.4%; six eyes)
Figure 2. CIE survival analysis for Mel4-coated lenses and control
lenses: (A) all participants, and (B) after removing the participant
who wore the lenses for 22 days (exceeding the maximum number
of days allowed in the trial).
whowore the control lenses. Six of the nine participants
with CIEs had CLARE, and three participants had IK.
All of these participants experienced unilateral CIEs.
The clinical features of CIEs with Mel4-coated lens
and control lens has shown in supplementary Figure
S1. The incidence of CIEs based on 100 participant-
months is presented in Figure 1A. The incidence rate
for CIEs in the Mel4-coated lenses (0.7 events per 100
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Figure 3. Number of days the study lenses were worn until adverse events occurred for (A) all participants and (B) those within the sched-
uled 14 days of lens wear. The box represents the median number of days, and the lines represent the total number of days.
participant-months) was approximately half that of the
control lenses (1.3 events per 100 participant-months).
However, there were no significant differences between
Mel4-coated lenses and control lenses (P = 0.51). One
of the CIEs in the Mel4-coated lenses occurred after
the participant had worn the lenses for 22 days, which
is outside the maximum number of days allowed in
the trial. When this case was removed for the analy-
sis, there was a 69% reduction in the incidence of CIEs
(Fig. 1B) for Mel4-coated lenses that had been worn
(0.4 events per 100 participant-months) compared with
control lenses that had been worn (1.3 events per 100
participant-months). However, this was also not statis-
tically different (P = 0.29).
Survival analyses for CIEs (Fig. 2A) found no signif-
icant differences betweenMel4 and control lenses (P =
0.32). Mel4-coated lens survival probability was 1.00
until 12 days and was reduced to 0.98 on the 47th
day. For the control lens, the survival probability was
1.00 on day one but dropped to 0.96 by the 68th day.
Removing the participant who wore the contact lenses
longer than prescribed resulted in the Mel4-coated
lenses having two events and the control lenses having
six events (Fig. 2B), but this was not a statistically
significant difference (P = 0.16). Figures 3A and 3B
show the number of days the study lenses were worn
until adverse events occurred and the number of days
the study lenses were wornwithin the scheduled 14 days
of lens wear until adverse events occurred. The median
number of days until adverse events occurred was 11
days (range, 2–14) for control lenses and 13 days (range,
13–22; 13 days only if the non-compliant lens wearer
was removed) for Mel4-coated lenses.
Microbial Growth From Contact Lenses and
Affected Eyes for CIE Participants
Of the nine participants’ contact lens samples,
eight lenses were available for culture. The results of
the microbiological analysis of the microbes grown
from the contact lenses of the affected eyes for the
participants with CIEs are presented in Table 1. Of
these, four samples (two Mel4-coated lenses and two
control lenses) did not show any growth of microbes.
Citrobacter diversus (a Gram-negative bacteria) was
cultured from one Mel4-coated lens (of subject 15).
Acinetobacter haemolyticus (a Gram-negative bacteria)
and Staphylococcus hominis (a Gram-positive bacteria)
were cultured from control lenses collected from two
participants.
All nine participants’ upper bulbar conjuncti-
val swabs were available for microbiological analy-
sis (Table 1). Of these, four samples (eye swabs
for two Mel4-coated lens wearers and two control
lens wearers) did not show any microbial growth.
The majority of the control lens conjunctival swabs
grew coagulase-negative staphylococci. No Gram-
negative bacteria or fungi were isolated from any
of the upper bulbar conjunctival swabs. One Gram-
negative bacterium, Acinetobacter lwoffii, was isolated
from the lid of an eye that wore a control lens
(Table 1). All other lid swabs of eyes that wore
the control lens grew various types of coagulase-
negative staphylococci.None of the lid swabs from eyes
that wore the Mel4-coated lenses grew any microbes.
No fungi were isolated from any of the lower lid
swabs.
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Table 1. Microbiological Analysis of theMicrobes Grown FromContact Lenses and Eyes of Participants Experienc-
ing CIEs
Location
Subject ID Diagnosis Contact Lens Contact Lens (CFU/lens) Upper Bulbar Conjunctiva (CFU/mL) Lower Lid Swab (CFU/mL)
15 CLARE Mel4-coated lens Citrobacter diversus (30) No growth No growth
117 CLARE No growth No growth No growth
103a,b IK No growth Staphylococcus gallinarum (2) No growth
37 CLARE Control lens Acinetobacter haemolyticus (1050) Staphylococcus epidermidis (1) Not available
68b CLARE No growth Staphylococcus epidermidis (5) Staphylococcus epidermidis (260) Acinetobacter lwoffii (3)
90 CLARE No growth No growth Staphylococcus hominis (7) Staphylococcus saprophyticus (3)
154 CLARE No growth Staphylococcus epidermidis (28) Staphylococcus epidermidis (3) Staphylococcus hominis (18)
6 IK Not available No growth Staphylococcus epidermidis (42)
19b IK Staphylococcus hominis (1) Staphylococcus hominis (1) Staphylococcus epidermidis (1)
aThis subject had worn the lenses for 22 days, outside of the 14-day wear schedule.
bThese participants had stored the contact lenses in the Biotrue contact lens solution rather than the PBS provided in the
red eye kit.
Table 2. Susceptibility of Gram-Negative Bacteria to Mel4 Peptide and Inhibition of Adhesion to Mel4-Coated
Lenses
Organism Minimum Inhibitory Concentration (μg/mL) Inhibition of Adhesion (log10)
Citrobacter diversus 15.6 2.14
Acinetobacter haemolyticus 62.5 2.10
Acinetobacter lwoffii 62.5 2.25
Susceptibility of the Gram-Negative Bacterial
Isolates to Mel4 andMel4-Coated Contact
Lenses
The Gram-negative bacteria isolated from partici-
pants with CIEs were susceptible to Mel4 in solution,
with minimum inhibitory concentrations ranging
between 15.6 and 62.5 μg/mL (Table 2). The Mel4-
coated contact lenses reduced the adhesion of these
Gram-negative bacteria by ≥2.1 log10 CFU/lens
(Table 2).
Discussion
This study for the first time, to our knowledge, inves-
tigated the ability of an antimicrobial peptide-coated
contact lens to reduce the incidence of CIEs during
extended human wear. Mel4-coated etafilcon A lenses
were associated with 50% to 69% fewer CIEs when
compared with control uncoated etafilcon A lenses.
The lack of a significant reduction in CIEs was most
likely due to the low rate of CIEs observed during
the study in the eyes that wore the control lenses.
The study sample size was calculated based on a 65%
reduction in CIEs from a previous study at the same
study site which reported a 6.7% rate of CIEs within a
period of 3 months34 in the same population wearing a
silicone hydrogel lens. This is considerably higher than
the rate of 1.3 CIEs per 100 participant-months (or
3.4% of the population) in the current study. Another
study, again using the same population, this time in a
bilateral extended-wear hydrogel (etafilcon A) lens
study conducted in the 1990s,38 found a CIE event rate
of 3.7 CIEs per 100 participant-months, again higher
than the current study (1.3 CIEs per 100 participant
months).
It is interesting to speculate why there was such a
reduction in the incidence of CIEs in the current study.
The current study used a contralateral design, whereas
other studies have used bilateral designs. It is possible
that participants in the current study swapped lenses
between eyes, although a protocol had been put in place
to prevent this from occurring. Participants were given
differently colored lens vials and told which color vial
should contain each eye’s lens. Also, participants were
reminded at each visit to be careful about remember-
ing which lens from which vial should go in which
eye. Also, approximately 50% of the study population
had different refractive errors in each eye, which would
make it unlikely that they would have swapped lenses,
as doing so would compromise their vision. Even so,
we cannot totally rule out the possibility of switching
lenses between eyes. The study from which the sample
size calculation datawere obtained investigated silicone
hydrogel lenses. Reports have suggested that adverse
event rates in silicone hydrogel lenses are approximately
twice the rate of those in hydrogel lenses.18,41 The
Downloaded from tvst.arvojournals.org on 07/05/2021
Effect of Antimicrobial Contact Lenses on CIEs TVST | June 2021 | Vol. 10 | No. 7 | Article 32 | 8
current study used etafilcon A hydrogel lenses, so the
apparent adverse event rate may have been reduced by
half compared with that used in the sample size calcu-
lation, which might have reduced the adverse event rate
to 3.5 per 100 participant-months, still considerably
higher than the 1.3 CIEs per 100 participant-months
in the current study.
A previous silicone hydrogel study39 designed to
examine the risk factors for CIEs found that people
who worked outdoors or in places where they were
exposed to wind, dust, fumes, and water splashes were
predisposed to inflammatory events (19.2% of such
people experienced CIEs). The current study recruited
82% of people who would have been classified as
working in ideal environments (68% of students and
14% hospital workers),39 so this may have contributed
to the reduced CIE event rate. The use of soft contact
lenses in teens and young adults increases the rate of
CIEs.42,43 The age range sits almost exactly within the
age range (15–25 years) reported previously to increase
the rate of adverse events during contact lens wear,42,43
so this should not have resulted in a lessening of the
CIE rate. However, the studies by Chalmers et al.41–43
were conducted on a US population, which may not be
directly comparable to an Indian population. People
with corneal vascularization may have higher adverse
event rates,39 but the current study excluded partici-
pants with corneal vascularization. Another factor that
might affect the CIE rate is lens movement.39 In the
current study, 94% of participants had an optimal lens
movement of 0.5 mm, and the remaining 6% had more
than 0.5 mm of lens movement.
In addition, LVPEI is a center of excellence for eye
care in India. In the current study, 25% of the study
participants had previously participated in contact lens
trails at LVPEI. Another 20% of the study participants
were optometry trainees in the hospital for their intern-
ship and fellowship programs, as well as first- to third-
year students who were studying optometry. There-
fore, 45% of the participants were well aware of the
care regimens required and had good training in the
management of contact lenses.
Other factors that might have contributed to the
very low CIE rate in the current study include changes
in the socioeconomic status of the population from
which the participants were drawn. The population
of Hyderabad increased from 6.73 million in 2011 to
10.86 million in 2017, when the study was conducted.
The gross domestic product of India increased from
US$1.827 trillion in 2012 to US$2.602 trillion in 2017.
Previous studies have demonstrated that the socioe-
conomic status of populations can affect the rates
of microbial keratitis15,44,45 and CIEs.46 Given that
the incidence of CIEs in the control eyes was less
than anticipated, a larger clinical trial with approx-
imately 350 participants (if using a contralateral
design, 3 months of lens wear, or 1050 participant-
months) to find a statistical reduction in CIEs is
necessary.
This study showed that three lenses collected from
CIEs were contaminated with S. hominis,A. haemolyti-
cus, or C. diversus. All of the other lenses collected
from infiltrative events were sterile. The three partic-
ipants with CIEs reported to the clinic with their
lenses in lens cases containing the Biotrue multipur-
pose disinfecting solution, despite repeated instruc-
tions to use the red eye kit and sterile saline. Although
this was a protocol violation, this violation would
not have affected the rates of CIEs in the current
study. The fact that Gram-negative bacteria on lenses
were associated with CLARE events confirms the
results of other studies.7–9 The Mel4-coated lenses
reduced bacterial adhesion by 2.14 log10 CFU/lens,
which is greater than the levels of inhibition produced
by Mel4 coatings on the adhesion of P. aeruginosa
(1.3 log10), Stenotrophomonas maltophilia (1.1 log10),
Elizabethkingia meningoseptica, (0.7 log10), Delftia
acidovorans (1.1 log10), and Burkholderia cepacia (0.5
log10).30,31 One Mel4-coated lens was contaminated
with C. diversus during an incidence of CLARE. The
CLARE event was observed at the end of the wear
period (day 13 of lens wear). Moreover, all of the CIEs
associated with Mel4-coated lenses that were not the
result of a protocol violation were reported on the 13th
day (or more for one participant) of extended wear,
perhaps suggesting that the lenses retained antimicro-
bial activity from the earlier wear period; however, this
would require confirmation.
There are possible limitations to this study. First,
the study sample size was found to be insufficient given
the low level of CIEs found in the population during
the study. Second, this study investigated the antimicro-
bial activity of a Mel4 coating on hydrogel etafilcon A
lenses rather than silicone hydrogel lenses. As approx-
imately 50% of contact lens wearers worldwide use
silicone hydrogel lenses, such lenses should be included
in future studies. Finally, the contralateral study design
may have resulted in subjects swapping lenses between
eyes. To overcome this limitation, future studies should
consider the use of different study designs.
Conclusions
To our knowledge, this is the first randomized
human clinical trial with Mel4-coated contact lenses
to show that these lenses have the capacity to reduce
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CIEs by at least 50% compared with uncoated control
lenses during extended wear over 3 months. However,
the reduction did not reach statistical significance due
to the low rate of CIEs observed with the control lenses
in the studied population at the time.
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